d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A Multicentre Open Randomized Phase II Study of the Efficacy and Safety of Azacitidine Alone or in Combination With Lenalidomide in High-risk Myeloid Disease (High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia) With a Karyotype Including Del(5q [Country] NO [Cancer type] 
Leukemia
Nordic NECT - Inclusion completed
Cancer type